semaglutide cvot trial In patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT SELECT Trial

Revive and restore your skin with Lemonbottle Master Cream, specially designed to repair damaged skin and enhance rejuvenation

and because it tells cells everywhere to grow, prolonged misuse is linked to fluid retention, joint pain, enlargement of organs (acromegaly-type effects), and a theoretical increase in cancer risk (Liv Hospital)

Those numbers will appear in the full scientific presentation

(2022) [59] comparing GLP-1RA plus SGLT2i combination therapy to GLP-1RA and SGLT2i monotherapies among 1,895 patients with T2DM enrolled in 8 RCTs, the addition of a GLP-1RA to SGLT2i treatment showed that drug discontinuation, diarrhea, injection-site-related events, nausea, vomiting and genital infections were more likely to occur in combination therapy